✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Dexcom Inc

Common Name
Dexcom
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
11,000
Ticker
DXCM
Exchange
NASDAQ/NGS
Description
Dexcom Inc. is a medical device company specializing in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for diabetes management and metabolic health in th...

Dexcom's Financial Statements Preview

Below are the financial statements of Dexcom, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
606.1a
566.3a
Short-term marketable securities
1,973.3a
2,157.8a
Accounts receivable, net
1,005.7a
973.9a
Inventory
542.6a
559.6a
Prepaid and other current assets
173.7a
168.3a
Total current assets
4,301.4a
4,425.9a
Property and equipment, net
1,339.9a
1,113.1a
Operating lease right-of-use assets
62.8a
71.4a
Goodwill
22.8a
25.2a
Intangibles, net
103.4a
134.5a
Deferred tax assets
481.2a
419.4a
Other assets
173a
75a
Total assets
6,484.5a
6,264.5a
Liabilities and stockholders’ equity
Current liabilities
Accounts payable and accrued liabilities
1,585.1a
1,345.5a
Accrued payroll and related expenses
112a
171a
Current portion of long-term senior convertible notes
1,204.4a
0a
Short-term operating lease liabilities
22.5a
21.1a
Deferred revenue
8a
18.4a
Total current liabilities
2,932a
1,556a
Long-term senior convertible notes
1,237a
2,434.2a
Long-term operating lease liabilities
65a
80.1a
Other long-term liabilities
147.9a
125.6a
Total liabilities
4,381.9a
4,195.9a
Stockholders’ equity
Preferred stock
0a
0a
Common stock
0.4a
0.4a
Additional paid-in capital
2,093.8a
3,514.6a
Accumulated other comprehensive loss
-8a
-16.7a
Retained earnings
1,597.6a
1,021.4a
Treasury stock, at cost
-1,581.2a
-2,451.1a
Total stockholders’ equity
2,102.6a
2,068.6a
Total liabilities and stockholders’ equity
6,484.5a
6,264.5a
Limited Data Preview
You are viewing a limited preview of Dexcom’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Dexcom’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Dexcom’s data sources below and access millions more through our Disclosure Search.

a. Dexcom's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?